ENGLISH
|
HINDI
APPS
iPhone
|
iPad
|
BlackBerry
|
Android
Nokia
Windows
Network18
Quotes
Quotes
NAVs
News
Messages
People
Notices
Videos
All
FEEDBACK
Facebook
Follow @moneycontrolcom on Twitter
CNBC TV 18
moneycontrol
News
Markets
Mutual Funds
IPO
Commodities
Wealth
Portfolio
Messages
My TV
Tax
Fixed Income
Property
SME
CNBC-TV18
Home
Business
General News
Market Trends
Stocks
Fund News
Personal Finance
Corporate Strategy
Lifestyle
Politics
Legal
Master Your Money
Share
>
Share
Tweet
Share on Tumblr
Kwizda Pharma
News »
latest
by relevance
Intas plans Filgrastim launch in North America, Europe
May 05, 2008 at 15:36
Intas plans Filgrastim launch in North America, Europe. IBPL and Apotex are keen to explore prospective business opportunities for more biosimilar products in the coming years.
Intas Biopharma & Kwizda complete clinical trial of Neukine
Apr 09, 2008 at 15:35
Intas Biopharmaceuticals Limited (IBPL) and European pharmaceutical major Kwizda Pharma GmbH has jointly completed Phase I clinical trial study of Neukine, biosimilar form of recombinant GCSF
Intas plans Filgrastim launch in North America, Europe
May 05, 2008 at 15:36
Intas plans Filgrastim launch in North America, Europe. IBPL and Apotex are keen to explore prospective business opportunities for more biosimilar products in the coming years.
Intas Biopharma & Kwizda complete clinical trial of Neukine
Apr 09, 2008 at 15:35
Intas Biopharmaceuticals Limited (IBPL) and European pharmaceutical major Kwizda Pharma GmbH has jointly completed Phase I clinical trial study of Neukine, biosimilar form of recombinant GCSF
Photos »
/
Follow moneycontrol.com
Facebook
Twitter
Google Plus
RSS
Wap SMS
SMS
Alert
iPad
iPhone
Blackberry
OVI
Android
Window
/ 
/
/